Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Series C Convertible Preferred Stock	Series D Convertible Preferred Stock	Common Stock	Exchangeable Shares	Proportionate Voting Shares	Preferred Stock Series A Convertible Preferred Stock	Preferred Stock Series B Convertible Preferred Stock	Preferred Stock Series C Convertible Preferred Stock	Common Shares Equivalent	Additional Paid In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-Controlling Interest
Balance at Dec. 31, 2020	$ (13,316)										$ 305,138	$ (3,662)	$ (318,594)	$ 3,802
Balance, shares at Dec. 31, 2020				79,526,785	38,890,571	76,307,000	14,258	710		209,692,379
Shares issued - stock option, warrant and RSU exercises	25,298										25,298
Shares issued - stock option, warrant and RSU exercises, shares		87,000	1,315,000	1,970,936						3,372,936
Private placement net of share issuance costs	173,477										173,477
Private placement net of share issuance costs, shares				18,115,656						18,115,656
Shares issued- conversion	560										560
Shares issued- conversion, shares		(87,000)	(1,315,000)	78,058,768		(76,307,000)	(250)	(100)
Share-based compensation expense	3,567										3,567
Options expired/forfeited											(53)		53
Conversion of convertible debt	(5,656)										(5,656)
Conversion of convertible debt, shares				1,284,221						1,284,221
Capital Contribution	(160)													(160)
Net loss	(14,111)												(14,174)	63
Foreign currency translation	2,189											2,189
Balance at Mar. 31, 2021	183,160										513,643	(1,473)	(332,715)	3,705
Balance, shares at Mar. 31, 2021				178,956,366	38,890,571		14,008	610		232,465,192
Balance at Dec. 31, 2021	228,954										535,418	2,823	(314,654)	5,367
Balance, shares at Dec. 31, 2021				190,930,800	38,890,571		13,708	610	36	244,175,394
Shares issued - stock option, warrant and RSU exercises	24,702										24,702
Shares issued - stock option, warrant and RSU exercises, shares				9,300,629						9,300,629
Shares, options and warrants issued- acquisitions	288,044										288,044
Shares, options and warrants issued - acquisitions, shares				51,349,978	13,504,500					64,854,478
Shares issued- liability settlement	22										22
Shares issued- liability settlement, shares				4,000						4,000
Shares issued- conversion, shares				385,819			(350)		(36)
Share-based compensation expense	3,356										3,356
Options expired/forfeited											(1,156)		1,156
Capital Contribution	(227)													(227)
Net loss	(16,006)												(16,357)	351
Foreign currency translation	(3,606)											(3,606)
Balance at Mar. 31, 2022	$ 525,239										$ 850,386	$ (783)	$ (329,855)	$ 5,491
Balance, shares at Mar. 31, 2022				251,971,226	52,395,071		13,358	610		318,334,501